Circulating Tumor Cell Market Predicted to Reach USD 5.9 Billion, Globally, by 2031 at 18.0% CAGR

Allied Market Research - Seite 2

Based on technology, the CTC detection and enrichment methods segment held the highest market share in 2021, accounting for nearly three-fifths of the global circulating tumor cell market, and is estimated to maintain its leadership status throughout the forecast period. This is owing to the advantages that this method offers over direct detection, such as rapid test results, high purity of detection of cells, fast and easy cell isolation techniques such as immunocapture. However, the CTC analysis segment is projected to manifest the highest CAGR of 19.0% from 2022 to 2031, owing to the rise in developments in this segment, such as utilization of FISH and RT PCR techniques for CTC detection and cancer diagnosis.

The clinical segment to maintain its leadership status throughout the forecast period

Based on application, the clinical segment held the highest market share in 2021, accounting for more than two-thirds of the global circulating tumor cell market, and is estimated to maintain its leadership status throughout the forecast period. This is owing to the rise in the adoption of CTC detection techniques in cancer diagnosis along with a rise in the number of cancer cases including breast, prostate, and colon cancer. However, the research segment is projected to manifest the highest CAGR of 18.6% from 2022 to 2031, owing to an increase in research and development activities in CTC detection and diagnosis of cancer. 

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/12283

The diagnostic centers segment to maintain its lead position during the forecast period

Based on end users, the diagnostic centers segment accounted for the largest share in 2021, contributing to more than half of the global circulating tumor cell market, and is projected to maintain its lead position during the forecast period. This is owing to the large number of patient visits to diagnostic centers after the COVID-19 pandemic, as they offer precise testing and assist healthcare providers to decide the treatment regime. The report also discusses segments including hospitals and clinics, and others. However, the others segment would achieve the fastest CAGR of 18.5% through 2031, owing to the rise in funding offered to research centers and academic research institutes by government and non-government organizations.